Metacrine | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)
Mar 24, 2023 17:29 ET
Metacrine | 8-K: Current report
Mar 24, 2023 17:28 ET
Metacrine | 4: Statement of changes in beneficial ownership of securities-Director Klassen Preston
Mar 24, 2023 12:35 ET
Metacrine | S-8 POS: S-8 POS
Mar 23, 2023 16:34 ET
Metacrine | S-8 POS: S-8 POS
Mar 23, 2023 16:32 ET
Metacrine | 8-K: Current report
Mar 23, 2023 16:31 ET
Metacrine | 8-K: Current report
Mar 15, 2023 17:20 ET
Metacrine | EFFECT: Others
Mar 8, 2023 00:15 ET
Metacrine | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Mar 3, 2023 17:25 ET
Metacrine | 8-K: Current report
Mar 3, 2023 17:23 ET
Metacrine | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
Mar 3, 2023 10:44 ET
Metacrine | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TANG CAPITAL PARTNERS, LP(9.98%),Tang Capital Management, LLC(9.98%), etc.
Feb 14, 2023 16:00 ET
Metacrine | DEF 14A: Definitive proxy statements
Feb 13, 2023 08:30 ET
Metacrine | 8-K: Current report
Feb 9, 2023 16:06 ET
Metacrine | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Braden M Leonard(15.9%),BML Investment Partners, L.P.(14.5%)
Feb 8, 2023 15:43 ET
Metacrine | 8-K: Current report
Feb 3, 2023 17:08 ET
Metacrine | 8-K: Current report
Feb 1, 2023 16:16 ET
Metacrine | 4: Statement of changes in beneficial ownership of securities
Jan 27, 2023 16:44 ET
Metacrine | 4: Statement of changes in beneficial ownership of securities
Jan 27, 2023 16:42 ET
Metacrine | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition
Jan 24, 2023 17:17 ET
No Data
No Data